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unimagined levels of complexity to these processes.
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Knowledge of the exact position of a 5’ transcriptional start
site (TSS) of an RNA molecule is crucial for the
identification of the regulatory regions that immediately
flank it. Traditionally, the most reliable method of
identifying a TSS is to map a nucleotide to which a 5’ cap
structure is added in the RNA. Over the past few years this
approach has been used in a number of genome-wide
surveys aimed at unbiased identification of TSSs (see [1,2]
and references therein). These surveys identified many
more sites where 5’ ends of capped RNAs could be mapped
than those TSSs belonging to annotated genes. At the same
time, large amounts of unannotated transcription had been
detected in mammalian genomes [2-4] and numerous
transcription factor binding sites found outside annotated
promoter regions [5,6]. In addition, multiple start sites are
often found for annotated, protein-coding genes very far
from their ‘official’ start sites [2,7,8]. 
Three papers published recently in Nature Genetics by
members of the FANTOM (Functional Annotation of
Mouse) consortium [9-11] reveal yet further complexity of
transcription initiation in animal genomes. Taft et al. [9]
describe a new class of short RNAs made at promoters,
while Faulkner et al. [10] show that repetitive elements can
be a rich source of novel promoters. A study from the
FANTOM consortium and the RIKEN Omics Science
Center [11] shows how information on the precise positions
of TSSs can be used to characterize global gene regulatory
networks operating during cell differentiation. 
H Ho ow w   t to o   i id de en nt ti if fy y   a a   t tr ra an ns sc cr ri ip pt ti io on n   s st ta ar rt t   s si it te e   
The critical issue in mapping a true site of transcription
initiation is to be able to distinguish it from a 5’ end
generated by RNA cleavage or degradation and from a
5’ end generated by incomplete copying of RNA into cDNA.
The conventional hallmark of TSSs in most eukaryotes is
addition of a 7-methyl guanosine cap structure to the
5’-triphosphate of the first base transcribed by RNA
polymerase II. This unique feature of the transcription
initiation nucleotide is the basis of several methods aiming
to enrich and identify capped messages and subsequently
to map the exact positions in the genome of the nucleotides
to which the cap is added. The main methods used are cap
analysis of gene expression (CAGE) [12], oligo-capping [13]
and robust analysis of 5’-transcript ends (5’-RATE) [14].
CAGE is the most commonly used and exploits the
2’,3’-diol structure of the cap nucleotide, which is only
present in only one other place on an RNA molecule
besides the cap - its extreme 3' end. The diol structure is
susceptible to a specific chemical oxidation which can be
followed by biotinylation, enabling selection of capped
messages by immunoprecipitation with streptavidin. The
enriched capped RNA fraction is then converted into
cDNAs that span the entire lengths of the capped RNA
molecules. Oligo-capping and 5’-RATE take advantage of
the fact that the 5’ cap is resistant to phosphatase
treatment, which removes mono-, di- or triphosphates
from cleaved or degraded RNA. Subsequent removal of the
cap using tobacco acid pyrophosphatase leaves a
5’-monophosphate, which is amenable to ligation with a
specific linker nucleotide that marks the position of the
native 5’ end of RNA and can later be used to select and
sequence the 5’ ends of capped cDNAs [13,14].
Full-length cDNAs generated by the techniques described
above can be further converted into short DNA tags derived
from their 5' ends [12,13,15], which are very suitable fornext-generation sequencing [16]. The combination of cap-
selection and next-generation sequencing can generate
sequence information about the exact positions of cap-
addition sites for millions of RNA molecules [4,15,17], thus
making it possible to obtain digital information about the
number of transcriptional initiation events occurring at any
genomic position. This information can be used to infer the
positions, as well as the relative strengths, of different
promoter elements [15], as exemplified in the recent articles
from the FANTOM consortium [9-11]. It can also be
correlated with information on the positions of other
annotated genomic elements, such as repetitive elements
[10] or short RNAs [9,18], to identify any association
between these elements and transcription initiation. 
C Co om mp pl le ex x   t tr ra an ns sc cr ri ip pt ti io on na al l   a ac ct ti iv vi it ty y   a ar ro ou un nd d   T TS SS Ss s      
The immediate vicinity of a TSS is active ground for the
production of a number of RNAs other than those destined
to become full-length, protein-coding mRNAs. These RNAs
can be transcribed from both DNA strands [19,20] and tend
to be either short [19,18,21] or short-lived and are quickly
degraded by the exosomal complex [22,23]. Working with
the Drosophila, human and chicken genomes, Taft et al. [9]
have now added a new class of promoter-related small
RNAs, dubbed ‘tiny RNAs’, which map within -60 to +120
nucleotides around a TSS, with a peak density at 10-30
nucleotides downstream of the TSS. The size of the tiny
RNAs, whose length distribution peaks at 18 nucleotides,
distinguishes them from the larger promoter-associated
short RNAs (PASRs) [19] and other RNAs generated at or
near a promoter [21,22]. The tiny RNAs can be mapped
mainly to the sense strand of the longer transcript and, like
PASRs, they tend to be found in the promoters of expressed
genes and associated with active chromatin marks [9]. 
An important question is whether any of the non-coding
RNAs found at or near promoters and TSSs have any
biological function, or whether they simply represent
byproducts of stalled polymerases or the degradation of
longer mRNAs. Several lines of evidence argue against the
latter two explanations. First, the observation by Taft et al.
[9] in Drosophila that only a fraction of tiny RNAs associate
with promoters that show evidence of stalled RNA
polymerase argues against abortive transcription as their
sole source. Taft et al. [9] also establish that production of
tiny RNAs and PASRs at promoters is common in organisms
as diverse as humans and flies, and that their relative
positions in the genome tend to be syntenically conserved
between between humans and chickens, similarly to PASRs
that are syntenically conserved between humans and mice
[19]. Third, synthetic single-stranded PASR RNA sequences
transfected into human cells can affect the expression of the
genes with which they associate [18]. Fourth, small RNAs
are found associated with 5’ ends of RNAs generated both by
transcriptional initiation and by cleavage [18]. In both cases,
the 5’ ends of these small RNAs are modified by the addition
of the cap, a modification known to protect RNAs against
degradation [24], and this is inconsistent with their being
mere degradation products on a path to complete removal
from the cell. 
R Re ep pe et ti it ti iv ve e   e el le em me en nt ts s: :   p pa ar ra as si it te es s   o or r   b bu ui il ld di in ng g   b bl lo oc ck ks s   o of f   t th he e
g ge en no om me e? ?         
Over the past few years, unbiased transcriptional surveys
have revealed that a large fraction of the genome can be
detected as stable transcripts [1,2,4]. However, these
experiments, often microarray-based, typically avoided
interrogating the repetitive element fraction of genomes as
hybridization signals could not be assigned to a unique
region. The advent of next-generation sequencing has made
it possible to uniquely assign an RNA sequence to a
particular repetitive element as long as there is some
divergence from other copies of the element in the genome.
Faulkner  et al. [10] have now shown that a significant
fraction of all CAGE tag clusters found in their study of
human and mouse could be uniquely mapped to repetitive
regions of the genome: 18.1% for mouse and 31.4% for
human, represented by 44,264 and 275,185 clusters,
respectively. Transcription within repetitive elements,
specifically within retrotransposons, is apparently driven by
their own promoters, which are surprisingly different from
those previously characterized for these elements, and is
highly tissue- and condition-specific. Faulkner et al. [10]
find that overall, 35% of retrotransposon-associated TSSs
show a restricted pattern of expression, compared to 17% of
the other TSSs. Conversely, different tissues express
different levels and types of repetitive elements, with human
embryonic tissues having the highest levels of CAGE tags in
these elements - 30% of all CAGE tags. 
The big question raised by this study is whether the large
contribution of repetitive elements, and retrotransposons in
particular, to a cell's transcriptome translates into a major
influence on its phenotype. In this respect, an important
aspect of the study of Faulkner et al. [10] is the finding that
retrotransposons might provide alternative or tissue-specific
promoters for protein-coding genes. In fact, 15,518 (in
mouse) and 117,165 (in human) of the putative novel TSSs
within retrotransposons were identified as being associated
with protein-coding transcripts, and the activity of 154
mouse and 579 human putative retrotransposon promoters
was confirmed from existing expressed sequence tag (EST)
data. Also, when Faulkner et al. [10] profiled 24 annotated
protein-coding genes with suspected alternative
retrotransposon promoters by rapid-amplification of cDNA
ends (RACE), eight were indeed found to have sequences
associating them with these promoters. Taken together,
these results show that repetitive elements could in fact
drive the production of a wide array of novel isoforms of
protein-coding genes whose regulation and coding potential
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be interesting to see how many of these putative protein-
coding transcripts initiating within repetitive elements are
actually translated.
This question could be phrased as part of a more general
question: what is the complexity of polypeptides made in
human cells, given the apparently high transcriptional
complexity of RNAs made from a protein-coding locus?
Analysis of available EST data has shown that, on average, a
protein-coding locus can produce 5.7 different isoforms [25].
Furthermore, unbiased profiling of every protein-coding
locus within the ENCODE regions has revealed that around
90% of them have either a novel internal exon or a novel TSS
that is used in at least one tissue tested, and that most of the
novel isoforms are tissue-specific [8]. It is not known,
however, what fraction of these novel transcripts is actually
translated and what fraction of such novel proteins would be
functional.
G Gl lo ob ba al l   r re eg gu ul la at ti io on n   o of f   t th he e   t tr ra an ns sc cr ri ip pt to om me e         
Precise knowledge of the TSSs used in a given biological
condition is indispensable for understanding how that
transcription is regulated. This is made abundantly clear by
the study from the FANTOM Consortium and the Riken
Omics Science Center [11], which modeled the
transcriptional regulatory networks of a differentiating
human cell. The authors used information on the genomic
positions of the regulatory regions for each transcript and
changes in transcript copy number during differentiation.
Promoters were identified as regions flanking clusters of
CAGE tags representing putative TSSs. For each promoter,
known motifs for transcription factor binding sites were
identified and this information was linked to changes in
expression levels of the downstream transcript to infer the
activity of the relevant transcription factors. From this, the
authors identified 30 motifs whose activity explained most
of the observed variation in gene expression; many of these
motifs correspond to known regulators of the differentiation
of macrophages - the particular cell type under study. The
main conclusion reached is that a large number of different
transcriptional regulators are required for differentiation, as
opposed to the model in which the process is controlled by a
small number of ‘master regulators’. 
A similar strategy could be applied to identify transcription
factors involved in regulation of other developmental or
disease systems. The information on the expression levels of
transcripts linked to individual TSSs is particularly
important, as the study described above [11] shows that
empirical mapping of TSSs can explain expression data
better than existing annotated TSSs can.
A caveat that must, however, be applied to techniques that
use an RNA cap to identify TSSs, is the recent discovery that
CAGE tags could represent 5' ends of RNAs generated by
cleavage and subsequent re-capping [18], and that
cytoplasmic enzyme complexes can add caps to
5'-monophosphate RNA molecules generated by
ribonuclease cleavage [26]. This means that mere knowledge
of the position of a capped nucleotide is not sufficient to
define a TSS. Additional information, such as the
distribution of putative initiation sites within a promoter
region [27], chromatin hallmarks associated with active
promotors, the presence of RNA polymerase II initiation
complexes and transcription factors [2,28] and appropriate
sequence content [29], will be required to prove that a true
initiation site has been identified and to re-evaluate the
number of TSSs in human and other genomes.
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